Year |
Citation |
Score |
2018 |
Randall EC, Emdal KB, Laramy JK, Kim M, Roos A, Calligaris D, Regan MS, Gupta SK, Mladek AC, Carlson BL, Johnson AJ, Lu FK, Xie XS, Joughin BA, Reddy RJ, et al. Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nature Communications. 9: 4904. PMID 30464169 DOI: 10.1038/S41467-018-07334-3 |
0.351 |
|
2018 |
Clark AR, Calligaris D, Regan MS, Pomeranz Krummel D, Agar JN, Kallay L, MacDonald T, Schniederjan M, Santagata S, Pomeroy SL, Agar NYR, Sengupta S. Rapid discrimination of pediatric brain tumors by mass spectrometry imaging. Journal of Neuro-Oncology. PMID 30128689 DOI: 10.1007/S11060-018-2978-2 |
0.424 |
|
2018 |
Kim M, Ma DJ, Calligaris D, Zhang S, Feathers RW, Vaubel RA, Meaux I, Mladek AC, Parrish KE, Jin F, Barriere C, Debussche L, Watters J, Tian S, Decker PA, et al. Efficacy of the MDM2 inhibitor SAR405838 in glioblastoma is limited by poor distribution across the blood-brain barrier. Molecular Cancer Therapeutics. PMID 29970480 DOI: 10.1158/1535-7163.Mct-17-0600 |
0.355 |
|
2018 |
Kim AJ, Basu S, Glass C, Ross EL, Agar N, He Q, Calligaris D. Unique intradural inflammatory mass containing precipitated morphine: confirmatory analysis by LESA-MS and MALDI-MS. Pain Practice : the Official Journal of World Institute of Pain. PMID 29480977 DOI: 10.1111/Papr.12688 |
0.353 |
|
2017 |
Cho CF, Wolfe JM, Fadzen CM, Calligaris D, Hornburg K, Chiocca EA, Agar NYR, Pentelute BL, Lawler SE. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nature Communications. 8: 15623. PMID 28585535 DOI: 10.1038/Ncomms15623 |
0.303 |
|
2017 |
Huang KT, Ludy S, Calligaris D, Dunn IF, Laws E, Santagata S, Agar NY. Rapid Mass Spectrometry Imaging to Assess the Biochemical Profile of Pituitary Tissue for Potential Intraoperative Usage. Advances in Cancer Research. 134: 257-282. PMID 28110653 DOI: 10.1016/Bs.Acr.2016.11.006 |
0.404 |
|
2017 |
Sun Y, Alberta JA, Pilarz C, Calligaris D, Chadwick EJ, Ramkissoon SH, Ramkissoon LA, Garcia VM, Mazzola E, Goumnerova L, Kane M, Yao Z, Kieran MW, Ligon KL, Hahn WC, et al. A brain-penetrant RAF dimer antagonist for the noncanonical BRAF oncoprotein of pediatric low-grade astrocytomas. Neuro-Oncology. PMID 28082416 DOI: 10.1093/Neuonc/Now261 |
0.324 |
|
2017 |
Lu FF, Calligaris D, Suo Y, Santagata S, Golby AJ, Xie XS, Mallory MA, Golshan M, Dillon DA, Agar NYR. Label-free biomolecular characterization of human breast cancer tissue with stimulated Raman scattering (SRS) spectral imaging (Conference Presentation) Proceedings of Spie. 10069. DOI: 10.1117/12.2253366 |
0.366 |
|
2017 |
Calligaris D, Clark A, Kallay L, Krummel DP, Agar J, Schniederjan M, Pomeroy S, Agar NY, Sengupta S. PATH-04. DISTINGUISHING PINEOBLASTOMA FROM MEDULLOBLASTOMAS USING TISSUE MASS SPECTROMETRY IMAGING Neuro-Oncology. 19: vi171-vi171. DOI: 10.1093/Neuonc/Nox168.695 |
0.39 |
|
2016 |
Jonas O, Calligaris D, Methuku KR, Poe MM, Francois JP, Tranghese F, Changelian A, Sieghart W, Ernst M, Krummel DA, Cook JM, Pomeroy SL, Cima M, Agar NY, Langer R, et al. First In Vivo Testing of Compounds Targeting Group 3 Medulloblastomas Using an Implantable Microdevice as a New Paradigm for Drug Development. Journal of Biomedical Nanotechnology. 12: 1297-302. PMID 27319222 DOI: 10.1166/Jbn.2016.2262 |
0.347 |
|
2016 |
Lu FK, Calligaris D, Olubiyi OI, Norton I, Yang W, Santagata S, Xie XS, Golby AJ, Agar NY. Label-Free Neurosurgical Pathology with Stimulated Raman Imaging. Cancer Research. PMID 27197198 DOI: 10.1158/0008-5472.Can-16-0270 |
0.402 |
|
2016 |
Sarkaria JN, Calligaris D, Ma D, Parrish K, Mladek AC, Laramy J, Kim M, Zhang S, Schroeder M, Carlson BL, Bakken K, Johnson A, Agar N, Elmquist W. Abstract B25: The critical importance of the blood-brain barrier in modulating the response to otherwise highly effective targeted therapies in patient-derived orthotopic glioblastoma xenografts Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B25 |
0.387 |
|
2015 |
Parrish KE, Cen L, Murray J, Calligaris D, Kizilbash S, Mittapalli RK, Carlson BL, Shroeder MA, Sludden J, Boddy AV, Agar NY, Curtin N, Elmquist WF, Sarkaria JN. Efficacy of PARP inhibitor rucaparib in orthotopic glioblastoma xenografts is limited by ineffective drug penetration into the central nervous system. Molecular Cancer Therapeutics. PMID 26438157 DOI: 10.1158/1535-7163.Mct-15-0553 |
0.378 |
|
2015 |
Calligaris D, Feldman DR, Norton I, Olubiyi O, Changelian AN, Machaidze R, Vestal ML, Laws ER, Dunn IF, Santagata S, Agar NY. MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation. Proceedings of the National Academy of Sciences of the United States of America. 112: 9978-83. PMID 26216958 DOI: 10.1073/Pnas.1423101112 |
0.376 |
|
2015 |
Kertesz V, Calligaris D, Feldman DR, Changelian A, Laws ER, Santagata S, Agar NY, Van Berkel GJ. Profiling of adrenocorticotropic hormone and arginine vasopressin in human pituitary gland and tumor thin tissue sections using droplet-based liquid-microjunction surface-sampling-HPLC-ESI-MS-MS. Analytical and Bioanalytical Chemistry. PMID 26084546 DOI: 10.1007/S00216-015-8803-2 |
0.39 |
|
2015 |
Calligaris D, Feldman DR, Norton I, Brastianos PK, Dunn IF, Santagata S, Agar NY. Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making. International Journal of Mass Spectrometry. 377: 690-698. PMID 25844057 DOI: 10.1016/J.Ijms.2014.06.024 |
0.43 |
|
2015 |
Ma D, Calligaris D, Zhang S, Kim M, Mladek A, Bakken K, Carlson B, Schroeder M, Kitange G, Agar N, Elmquist W, Sarkaria J. DDEL-15MANIPULATION OF THE BLOOD-BRAIN-BARRIER RESTORES THE EFFICACY OF MDM2 INHIBITION IN ORTHOTOPIC GLIOBLASTOMA MODELS Neuro-Oncology. 17: v76.3-v76. DOI: 10.1093/Neuonc/Nov212.15 |
0.374 |
|
2015 |
Calligaris D, Feldman DR, Norton I, Olubiyi O, Changelian AN, Machaidze R, Vestal ML, Laws ER, Dunn IF, Santagata S, Agar NYR, Meinwald J. MALDI mass spectrometry imaging analysis of pituitary adenomas for near-real-time tumor delineation Proceedings of the National Academy of Sciences of the United States of America. 112: 9978-9983. DOI: 10.1073/pnas.1423101112 |
0.326 |
|
2014 |
Calligaris D, Caragacianu D, Liu X, Norton I, Thompson CJ, Richardson AL, Golshan M, Easterling ML, Santagata S, Dillon DA, Jolesz FA, Agar NY. Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis. Proceedings of the National Academy of Sciences of the United States of America. 111: 15184-9. PMID 25246570 DOI: 10.1073/Pnas.1408129111 |
0.378 |
|
2014 |
Sounni NE, Cimino J, Blacher S, Primac I, Truong A, Mazzucchelli G, Paye A, Calligaris D, Debois D, De Tullio P, Mari B, De Pauw E, Noel A. Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal. Cell Metabolism. 20: 280-94. PMID 25017943 DOI: 10.1016/J.Cmet.2014.05.022 |
0.496 |
|
2014 |
Santagata S, Eberlin LS, Norton I, Calligaris D, Feldman DR, Ide JL, Liu X, Wiley JS, Vestal ML, Ramkissoon SH, Orringer DA, Gill KK, Dunn IF, Dias-Santagata D, Ligon KL, et al. Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery. Proceedings of the National Academy of Sciences of the United States of America. 111: 11121-6. PMID 24982150 DOI: 10.1073/Pnas.1404724111 |
0.436 |
|
2014 |
Calligaris D, Loginov D, Machaidze R, Alberta JA, Stiles CD, Love JC, Agar NYR. Ni-10A Mass Spectrometry Imaging Platform To Study Drug-Susceptibility Of Brain Tumors Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou264.10 |
0.432 |
|
2014 |
Jonas O, Sengupta S, Calligaris D, Poe M, Methuku K, Francois JP, Cook J, Agar N, Pomeroy S, Langer R. ET-24 * A NOVEL TROJAN HORSE FOR IN-VIVO SENSITIVITY TESTING OF MEDULLOBLASTOMA THERAPIES Neuro-Oncology. 16: v84-v84. DOI: 10.1093/Neuonc/Nou255.24 |
0.346 |
|
2014 |
Jadoul L, Malherbe C, Calligaris D, Longuespée R, Gilbert B, Eppe G, De Pauw E. Matrix-assisted laser desorption/ionization mass spectrometry and Raman spectroscopy: An interesting complementary approach for lipid detection in biological tissues European Journal of Lipid Science and Technology. 116: 1080-1086. DOI: 10.1002/Ejlt.201300198 |
0.546 |
|
2013 |
Cimino J, Calligaris D, Far J, Debois D, Blacher S, Sounni NE, Noel A, De Pauw E. Towards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imaging. International Journal of Molecular Sciences. 14: 24560-80. PMID 24351834 DOI: 10.3390/Ijms141224560 |
0.55 |
|
2013 |
Calligaris D, Norton I, Feldman DR, Ide JL, Dunn IF, Eberlin LS, Cooks RG, Jolesz FA, Golby AJ, Santagata S, Agar NY. Mass spectrometry imaging as a tool for surgical decision-making. Journal of Mass Spectrometry : Jms. 48: 1178-87. PMID 24259206 DOI: 10.1002/Jms.3295 |
0.407 |
|
2013 |
Asakawa D, Calligaris D, Zimmerman TA, De Pauw E. In-source decay during matrix-assisted laser desorption/ionization combined with the collisional process in an FTICR mass spectrometer. Analytical Chemistry. 85: 7809-17. PMID 23879863 DOI: 10.1021/Ac401234Q |
0.625 |
|
2013 |
Asakawa D, Calligaris D, Smargiasso N, De Pauw E. Ultraviolet laser induced hydrogen transfer reaction: study of the first step of MALDI in-source decay mass spectrometry. The Journal of Physical Chemistry. B. 117: 2321-7. PMID 23360482 DOI: 10.1021/Jp311464K |
0.496 |
|
2013 |
Calligaris D, Longuespée R, Debois D, Asakawa D, Turtoi A, Castronovo V, Noël A, Bertrand V, De Pauw-Gillet MC, De Pauw E. Selected protein monitoring in histological sections by targeted MALDI-FTICR in-source decay imaging. Analytical Chemistry. 85: 2117-26. PMID 23323725 DOI: 10.1021/Ac302746T |
0.579 |
|
2013 |
Ait-Belkacem R, Calligaris D, Sellami L, Villard C, Granjeaud S, Schembri T, Berenguer C, Ouafik L, Figarella-Branger D, Chinot O, Lafitte D. Tubulin isoforms identified in the brain by MALDI in-source decay Journal of Proteomics. 79: 172-179. PMID 23279932 DOI: 10.1016/J.Jprot.2012.11.026 |
0.42 |
|
2012 |
Ait-Belkacem R, Sellami L, Villard C, DePauw E, Calligaris D, Lafitte D. Mass spectrometry imaging is moving toward drug protein co-localization Trends in Biotechnology. 30: 466-474. PMID 22762968 DOI: 10.1016/J.Tibtech.2012.05.006 |
0.437 |
|
2011 |
Calligaris D, Villard C, Lafitte D. Advances in top-down proteomics for disease biomarker discovery Journal of Proteomics. 74: 920-934. PMID 21477672 DOI: 10.1016/J.Jprot.2011.03.030 |
0.35 |
|
Show low-probability matches. |